SCORE2 Report 5: Vision-Related Function in Patients with Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Documenti analoghi

• Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4
  di: Scott, Ingrid U., et al.
  Pubblicazione: (2017)
• Month 24 Outcomes After Treatment Initiation With Anti–Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial
  di: Scott, Ingrid U., et al.
  Pubblicazione: (2019)
• Month 12 Outcomes After Treatment Change at Month 6 Among Poor Responders to Aflibercept or Bevacizumab in Eyes With Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study
  di: Ip, Michael S., et al.
  Pubblicazione: (2018)
• SCORE Study Report 15: Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure after Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion
  di: Aref, Ahmad A., et al.
  Pubblicazione: (2015)
• A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5
  di: Ip, Michael S., et al.
  Pubblicazione: (2009)